Are you Dr. Kelly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 84 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Endocrinology
Philadelphia, PA 19104Phone+1 215-590-3174Fax+1 215-590-3053
Summary
- Dr. Andrea Kelly, MD is a pediatric endocrinologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Children's Hospital of Philadelphia, Hospital of the University of Pennsylvania, and Pennsylvania Hospital.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Endocrinology, 1998 - 2001
- Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1995 - 1998
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
- PA State Medical License 1996 - 2024
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes Start of enrollment: 2005 Oct 01
- Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis Start of enrollment: 2008 Mar 01
- Down Syndrome Metabolic Health Study Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 106 citationsHyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase.Courtney MacMullen, Jie Fang, Betty Y.L. Hsu, Andrea Kelly, Pascale de Lonlay-Debeney
The Journal of Clinical Endocrinology and Metabolism. 2001-04-01 - 137 citationsThe stepwise assembly of the neonatal virome is modulated by breastfeedingGuanxiang Liang, Chunyu Zhao, Huanjia Zhang, Lisa M. Mattei, Scott Sherrill-Mix
Nature. 2020-04-15 - 130 citationsClinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.David P. Nichols, Alex C Paynter, Sonya L. Heltshe, Scott H. Donaldson, Carla A. Frederick
American Journal of Respiratory and Critical Care Medicine. 2021-11-16
Press Mentions
- Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes, Penn Study FindsJuly 21st, 2022
- Business Summary | Business | Herald Dispatch.comJuly 18th, 2021
- Istari Oncology Presents Positive Data from Phase 1 Study of PVSRIPO in Patients with Unresectable Treatment Refractory Melanoma at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual MeetingNovember 9th, 2020